"The lower, the better": pas d'accord sur le rapport benefices/risques apres "ACCORD".

SCHEEN, André

Download

Article (Scientific journals)

"The lower, the better": pas d'accord sur le rapport benefices/risques apres "ACCORD".

SCHEEN, André

2011 • In Revue Médicale Suisse, 7 (306), p. 1603-4

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/104962

PubMed
21972725

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

RMS_the lower tne better.pdf

Publisher postprint (553.09 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Blood Glucose/analysis; Blood Pressure; Cardiovascular Diseases/prevention & control; Humans; Randomized Controlled Trials as Topic

Disciplines :

Endocrinology, metabolism & nutrition
Pharmacy, pharmacology & toxicology

Author, co-author :

SCHEEN, André ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques

Language :

French

Title :

"The lower, the better": pas d'accord sur le rapport benefices/risques apres "ACCORD".

Alternative titles :

[en] "The lower, the better:" this was not confirmed in the risk/benefit report of the ACCORD trial

Publication date :

2011

Journal title :

Revue Médicale Suisse

ISSN :

1660-9379

Publisher :

Medecine et Hygiène, Switzerland

Volume :

Issue :

306

Pages :

1603-4

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 08 December 2011

Statistics

Number of views

77 (2 by ULiège)

Number of downloads

80 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

Bibliography

Scheen AJ, Paquot N. Approche multirisque du patient diabétique de type 2: désaccord sur les valeurs cibles suite à l'étude ACCORD. Rev Med Suisse 2010;6:1582-7.